Neurological products and therapies news

Renishaw, a global engineering company with expertise in healthcare, is exhibiting at the International Symposium on Paediatric Neuro-Oncology (ISPNO) 2018. From June 30th to July 3rd at the Hyatt Regency Hotel in Denver, Colorado, USA the company will showcase its neurological products which improve accuracy and reduce procedure time in neurosurgery.

From June 24th to June 27th, 2018, global engineering technologies company Renishaw will attend the Canadian Neurological Sciences Federation’s annual congress. The event, held at the Halifax Convention Centre, Nova Scotia, provides multidisciplinary courses relevant to all neuroscience specialities. On booth 304, Renishaw will showcase its neuromate® stereotactic robot and neuroinspire™ its surgical planning software.

The Food and Drug Association (FDA) has recently cleared the use of Renishaw’s neuromate® Gen III surgical robot with the neuroinspire™ surgical planning software in the USA. Both were previously cleared for use separately, but not in combination ─ This latest clearance means that neurosurgeons across America will now be able to deliver surgical plans created using neuroinspire software directly using the neuromate surgical robot, helping to improve patient outcomes.

Neurosurgeons at The Walton Centre, Liverpool, UK, have recently carried out their first two stereoelectroencephalography (SEEG) procedures with the assistance of the Renishaw neuromate stereotactic robot. The Walton Centre is the only NHS Trust in the UK dedicated to neuroscience, and the staff includes many leaders in their areas of expertise.

Renishaw is pleased to be returning to BioWales as an exhibitor and sponsor of the gala dinner.